Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Pilot Study of RR-HNK in OCD [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announcing a pilot study of RR-HNK for obsessive-compulsive disorder, spanning Phase 1 and Phase 2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RR-HNK (RR-HNK)

Snippet

Sponsor: Carolyn Rodriguez | Conditions: Obsessive-Compulsive Disorder | Phase 1, Phase 2 | Status: RECRUITING